Table 1.
Gender | Male | 346 (57.6%) |
Female | 255 (42.4%) | |
Age (year) | Median 50 (18–83) | |
Distance from anal verge (cm) | Median 5 (1–15) | |
Tumor size (cm) | Median 0.7 (0.2-13.0) | |
Tumor grade | G1 | 515 (85.7%) |
G2 | 86 (14.3%) | |
Invading depth | T0 | 399 (66.4%) |
T1 | 114 (19.0%) | |
T2 | 34 (5.7%) | |
T3 | 31 (5.2%) | |
T4 | 21 (3.5%) | |
N stage | N0 | 536 (89.2%) |
N1 | 65 (10.8%) | |
M stage | M0 | 563 (93.7%) |
M1 | 38 (6.3%) | |
ENETS TNM stage | Ia | 392 (65.2%) |
Ib | 108 (18.0%) | |
II | 21 (3.5%) | |
III | 42 (7.0%) | |
IV | 38 (6.3%) | |
Microvascular invasion | no | 293 (48.8%) |
yes | 19 (3.2%) | |
unknown | 289 (48.1%) | |
Perineural invasion | no | 288 (47.9%) |
yes | 19 (3.2%) | |
unknown | 294 (48.9%) | |
Surgical modality | none | 13 (2.1%) |
EMR | 49 (8.2%) | |
ESD | 196 (32.6%) | |
TEM | 266 (44.3%) | |
AR/APR/hartman | 77 (12.8%) |
EMR, Endoscopic Mucosal Resection; ESD, Endoscopic Submucosal Dissection; TEM, Transanal Endoscopic Microsurgery; AR, Anterior Resection; APR, Abdomen Perineal Resection.